Wave Life Sciences (WVE) Interest Expenses (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Interest Expenses came in at $41000.0 in Q2 2026, down 99.98% on a QoQ basis from $272.3 million in Q4 2024.
Wave Life Sciences (WVE) Interest Expenses (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 12 years of Interest Expenses data on file, last reported at $41000.0 in Q2 2026.
- Quarterly Interest Expenses changed N/A year-over-year to $41000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $41000.0 (changed N/A YoY) and the FY2025 annual result came in at $326.7 million, up 19.97% from the prior year.
- Interest Expenses fell to $41000.0 in Q2 2026, from $272.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $272.3 million in Q4 2024 to a low of $41000.0 in Q2 2026.
- A 4-year average of $186.5 million and a median of $236.7 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses fell 5.0% — and 2024, when it rose 10.16%.
- Tracing WVE's Interest Expenses over 4 years: stood at $226.3 million in 2022, then advanced by 9.25% to $247.2 million in 2023, then increased by 10.16% to $272.3 million in 2024, then tumbled by 99.98% to $41000.0 in 2026.
- The last three Interest Expenses figures came in at $41000.0 (Q2 2026), $272.3 million (Q4 2024), and $247.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | 41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41,000.00 |
| Jun 30, 2026 | 41,000.00 |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 272.31 Mn |
| Dec 31, 2024 | 272.31 Mn |
| Dec 31, 2023 | 247.19 Mn |
| Dec 31, 2023 | 247.19 Mn |
| Dec 31, 2022 | 226.27 Mn |
| Dec 31, 2022 | 226.27 Mn |
| Dec 31, 2021 | 238.17 Mn |
| Dec 31, 2021 | 238.17 Mn |
| Dec 31, 2020 | 195.38 Mn |
| Dec 31, 2020 | 195.38 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Sep 30, 2019 | 45.67 Mn |
| Sep 30, 2019 | 45.67 Mn |
| Jun 30, 2019 | 6.02 Mn |
| Jun 30, 2019 | 6.02 Mn |